References

Assenov, Y., F. Ramirez, S.E. Schelhorn, T. Lengauer and M. Albrecht, 2008. Computing topological parameters of biological networks. Bioinformatics, 24: 282-284.
Direct Link  |  

Barabasi, A.L. and R. Albert, 1999. Emergence of scaling in random networks. Science, 286: 509-512.
CrossRef  |  Direct Link  |  

Barabasi, A.L. and Z.N. Oltvai, 2004. Network biology: Understanding the cell's functional organization. Nat. Rev. Genet., 5: 101-113.
CrossRef  |  PubMed  |  Direct Link  |  

Cases, M. and J. Mestres, 2009. A chemogenomic approach to drug discovery: Focus on cardiovascular diseases. Drug Discov. Today, 14: 479-485.
CrossRef  |  

Chautard, E., N. Thierry-Mieg and S. Ricard-Blum, 2009. Interaction networks: From protein functions to drug discovery. A review. Pathol. Biol., 57: 324-333.
CrossRef  |  

Cheng, F., C. Liu, J. Jiang, W. Lu and W. Li et al., 2012. Prediction of drug-target interactions and drug repositioning via network-based inference. PLoS Comput. Biol., Vol. 8. 10.1371/journal.pcbi.1002503

Chrysant, S.G., M.A. Weber, A.C. Wang and D.J. Hinman, 2004. Evaluation of antihypertensive therapy with the combination of olmesartan medoxomil and hydrochlorothiazide. Am. J. Hypertens., 17: 252-259.
Direct Link  |  

Csermely, P., V. Agoston and S. Pongor, 2005. The efficiency of multi-target drugs: The network approach might help drug design. Trends. Pharmacol. Sci., 26: 178-182.
Direct Link  |  

Dong, J. and S. Horvath, 2007. Understanding network concepts in modules. BMC Syst. Biol., Vol. 1. 10.1186%2F1752-0509-1-24

Forbes, C.D., 1998. Secondary stroke prevention with low-dose aspirin, sustained release dipyridamole alone and in combination. ESPS Investigators. European Stroke Prevention Study. Thromb. Res., 92: S1-S6.
Direct Link  |  

Ho, D.D., 1995. Time to hit HIV, early and hard. N. Engl. J. Med., 333: 450-451.
Direct Link  |  

Hopkins, A.L., 2008. Network pharmacology: The next paradigm in drug discovery. Nat. Chem. Biol., 4: 682-690.
CrossRef  |  Direct Link  |  

Jeong, H., S.P. Mason, A.L. Barabasi and Z.N. Oltvai, 2001. Lethality and centrality in protein networks. Nature, 411: 41-42.
CrossRef  |  Direct Link  |  

Kairuz, T.E., D. Gargiulo, C. Bunt and S. Garg, 2007. Quality, safety and efficacy in the off-label use of medicines. Curr. Drug Saf., 2: 89-95.
Direct Link  |  

Kerrien, S., B. Aranda, L. Breuza, A. Bridge and F. Broackes-Carter et al., 2012. The IntAct molecular interaction database in 2012. Nucleic Acids Res., 40: D841-D846.
Direct Link  |  

Knox, C., V. Law, T. Jewison, P. Liu and S. Ly et al., 2011. DrugBank 3.0: A comprehensive resource for omics research on drugs. Nucleic Acids Res., 39: D1035-D1041.
CrossRef  |  Direct Link  |  

Kotlyar, M., K. Fortney and I. Jurisica, 2012. Network-based characterization of drug-regulated genes, drug targets and toxicity. Methods, 57: 499-507.
CrossRef  |  

Kroeze, W.K., K. Kristiansen and B.L. Roth, 2002. Molecular biology of serotonin receptors structure and function at the molecular level. Curr. Top. Med. Chem., 2: 507-528.
Direct Link  |  

Lee, S., K. Park and D. Kim, 2009. Building a drug-target network and its applications. Exp. Opin. Drug Discov., 4: 1177-1189.
CrossRef  |  

Marre, M. and T. Allavoine, 2000. Response rate in second-line therapy of a new fixed combination metformin/glibenclamide product. Diabetes Res. Clin. Pract., 50: 343-343.
Direct Link  |  

Paolini, G.V., R.H. Shapland, W.P. van Hoorn, J.S. Mason and A.L. Hopkins, 2006. Global mapping of pharmacological space. Nat. Biotechnol., 24: 805-815.
Direct Link  |  

Prasad, T.S.K., R. Goel, K. Kandasamy, S. Keerthikumar and S. Kumar et al., 2009. Human protein reference database: 2009 update. Nucleic Acids Res., 37: D767-D772.
CrossRef  |  Direct Link  |  

Raffa, R.B., R. Clark-Vetri, R.J. Tallarida and A.I. Wertheimer, 2003. Combination strategies for pain management. Exp. Opin. Pharmacother., 4: 1697-1708.
Direct Link  |  

Roth, B.L., J.S. Douglas and K.K. Wesley, 2004. Magic shotguns versus magic bullets: Selectively non-selective drugs for mood disorders and schizophrenia. Nat. Rev. Drug Discov., 3: 353-359.
CrossRef  |  Direct Link  |  

Ruffner, H., A. Bauer and T. Bouwmeester, 2007. Human protein-protein interaction networks and the value for drug discovery. Drug Discov. Today, 12: 709-716.
CrossRef  |  

Salwinski, L., C.S. Miller, A.J. Smith, F.K. Pettit and J.U Bowie, D. Eisenberg, 2004. The database of interacting proteins. Nucleic Acids Res., 32: 449-451.
PubMed  |  Direct Link  |  

Scheffer, R.E., 2004. Abnormal neurological signs at the onset of psychosis. Schizophrenia Res., 70: 19-26.
CrossRef  |  

Smoot, M.E., K. Ono, J. Ruscheinski, P.L. Wang and T. Ideker, 2011. Cytoscape 2.8: New features for data integration and network visualization. Bioinformatics, 27: 431-432.
CrossRef  |  PubMed  |  

Stark, C., B.J. Breitkreutz, A. Chatr-Aryamontri, L. Boucher and R. Oughtred et al., 2011. The BioGRID interaction database: 2011 update. Nucleic Acids Res., 39: D698-D704.
Direct Link  |  

Sud'ina, G.F., M.A. Pushkareva, P. Shephard and T. Klein, 2008. Cyclooxygenase (COX) and 5-lipoxygenase (5-LOX) selectivity of COX inhibitors. Prostaglandins Leukot. Essent. Fatty Acids, 78: 99-108.
CrossRef  |  

Tao, W., X. Xu, X. Wang, B. Li, Y. Wang, Y. Li and L. Yang, 2013. Network pharmacology-based prediction of the active ingredients and potential targets of Chinese herbal Radix Curcumae formula for application to cardiovascular disease. J. Ethnopharmacol., 145: 1-10.
CrossRef  |  Direct Link  |  

Vogt, I. and J. Mestres, 2010. Drug-target networks. Mol. Inform., 29: 10-14.
CrossRef  |  

Weber, A., A. Casini, A. Heine, D. Kuhn, C.T. Supuran, A. Scozzafava and G. Klebe, 2004. Unexpected nanomolar inhibition of carbonic anhydrase by COX-2-selective celecoxib: New pharmacological opportunities due to related binding site recognition. J. Med. Chem., 47: 550-557.
CrossRef  |  Direct Link  |  

Xu, Z., 2011. One step at a time. Nature, 480: S90-S92.

Yamanishi, Y., M. Araki, A. Gutteridge, W. Honda and M. Kanehisa, 2008. Prediction of drug-target interaction networks from the integration of chemical and genomic spaces. Bioinformatics, 24: i232-i240.
CrossRef  |  

Yildirim, M.A., K.I. Goh, M.E. Cusick, A.L. Barabasi and M. Vidal, 2007. Drug-target network. Nat. Biotechnol., 25: 1119-1126.
Direct Link  |